Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00818961 · OUTCOME

Number of Patients Requiring the Use of Donor Leukocyte Infusion (DLI) for Early Mixed T-cell Chimerism

Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Cancer · Source last updated 2013-12-18

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
participants
Interval / dispersion
Not reported
Time frame
Day 100

What was measured

DLI is used for patients with mixed chimerism following transplant

Analysis population: 36 patients underwent hematopoietic stem cell transplant and therefore were eligible for donor leukocyte infusions for mixed chimerism following transplant

Groups in this outcome

Hematopoietic Stem Cell Transplantation

All patients receive a hematopoietic stem cell transplant using one of two chemotherapy regimens based on disease type

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Hematopoietic Stem Cell Transplantation36

Reported measurements

Source class 1
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Hematopoietic Stem Cell Transplantation19Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        19
denoms
  1. counts
    1. group Id
      OG000
      value
      36
    units
    Participants
description
DLI is used for patients with mixed chimerism following transplant
groups
  1. description
    All patients receive a hematopoietic stem cell transplant using one of two chemotherapy regimens based on disease type
    id
    OG000
    title
    Hematopoietic Stem Cell Transplantation
param Type
NUMBER
population Description
36 patients underwent hematopoietic stem cell transplant and therefore were eligible for donor leukocyte infusions for mixed chimerism following transplant
reporting Status
POSTED
time Frame
Day 100
title
Number of Patients Requiring the Use of Donor Leukocyte Infusion (DLI) for Early Mixed T-cell Chimerism
type
SECONDARY
unit Of Measure
participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice